• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HU Zhongfang, SONG Min, HANG Taijun. Studies on related substances in cinacalcet hydrochloride by LC-MS[J]. Journal of China Pharmaceutical University, 2016, 47(6): 719-726. DOI: 10.11665/j.issn.1000-5048.20160615
Citation: HU Zhongfang, SONG Min, HANG Taijun. Studies on related substances in cinacalcet hydrochloride by LC-MS[J]. Journal of China Pharmaceutical University, 2016, 47(6): 719-726. DOI: 10.11665/j.issn.1000-5048.20160615
shu

Studies on related substances in cinacalcet hydrochloride by LC-MS

More Information
    Graphical Abstract
    • Abstract
  • To develop an LC-MS method for the separation and identification of the related substances in cinacalcet hydrochloride. The separation was carried out on a Thermo BDS Hypersil C18 column(100 mm×4. 6 mm, 2. 4 μm)with mobile phase consisting of 0. 1% ammonium acetate buffer-acetonitrile(93∶7)(A)and acetonitrile(B)by gradient elution. The related substances were identified by electrospray positive ionization high resolution TOF/MS and MS/MS, and verified further through reference substances. Cinacalcet hydrochloride and itsrelated substances were separated under the established LC-MS condition. Ten related substances were detected and identified to be one starting material, one intermediate, four synthetic by-products and five degradation products. It showed that the LC-MS method was useful for separating and identifying the related substances in cinacalcet hydrochloride. And the results obtained are valuable for cinacalcet hydrochloride manufacturing process control and quality assurance.
    • FullText(HTML)
    • References (14)
  • [1]
    Dong BJ.Cinacalcet:an oral calcimimetic agent for the management of hyperparathyroidism[J].Clin Ther,2005,27(11):1725-1751.
    [2]
    Sajid-Crockett S, Singer FR, Hershman JM. Cinacalcet for the treatment of primary hyperparathyroidism[J].Metabolism,2008,57(4):517-521.
    [3]
    Martín AA,Villalón AA,Ramírez ML,et al.Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery[J].Endocrinol Nutr,2011,58(1):24-31.
    [4]
    Somnay YR, Weinlander E, Schneider DF, et al. The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy[J].Surgery,2014,156(6):1308-1314.
    [5]
    Nirogi R, Kandikere V, Komarneni P, et al. Quantification of cinacalcet by LC-MS/MS using liquid-liquid extraction from 50 μL of plasma[J].J Pharm Biomed Anal,2011,56(2):373-381.
    [6]
    Yang F,Wang HY,Zhao Q,et al.Determination of cinacalcet hydrochloride in human plasma by liquid chromatography-tandem mass spectrometry[J].J Pharm Biomed Anal,2012,61:237-241.
    [7]
    Zhao L,Zhao CC,Lu C,et al.Content determination of cinacalcet hydrochloride tablets by HPLC[J].J China Pharm(中国药房),2014,25(13):1216-1217.
    [8]
    Zhu JX,Zhuang BY,Zeng FX,et al.Determination of the related substances of cinacalcet hydrochloride by HPLC[J].Chin J Mod Appl Pharm(中国现代应用药学),2015,32(2):185-189.
    [9]
    Thiel OR,Bernard C,Tormos W,et al.Practical synthesis of the calcimimetic agent,cinacalcet[J].Tetrahedron Lett,2008,49(1):13-15.
    [10]
    Hu J,Dong J,Shi XX.Synthesis of cinacalcet hydrochloride[J].Chin J Pharm(中国医药工业杂志),2010,41(7):488-490.
    [11]
    Li LL,Hu XF,Yang YL,et al.Synthesis process of cinacalcet hydrochloride[J].Chin New Drugs J(中国新药杂志),2013,22(7):834-836.
    [12]
    Prediger P,Silva AR,Correia CRD.Construction of 3-arylpropylamines using Heck arylations.The total synthesis of cinacalcet hydrochloride,alverine,and tolpropamine[J].Tetrahedron,2014,70(20):3333-3341.
    [13]
    Gooodman CA,Janci EM,Onwodi O,et al.A two-step,one pot preparation of amines via acyl succinimides.Synthesis of the calcimimetic agents cinacalcet,NPS R-467,and NPS R-568[J].Tetrahedron Lett,2015,56(44):4468-4471.
    [14]
    Chen LL,Song M,Zhang G,et al. Identification of related substances in ambrisentan by LC-MS/MS[J].J China Pharm Univ(中国药科大学学报),2016,47(1):58-65.
    • Related Articles

  • Related Articles

    [1]XU Tao, WANG Xiaowei, LIU Xiaorong, WANG Yazhou, LI Zhiyu. Design, synthesis and biological evaluation of ALK5 inhibitors[J]. Journal of China Pharmaceutical University, 2020, 51(4): 441-448. DOI: 10.11665/j.issn.1000-5048.20200408
    [2]WANG Lei, MA Jun, GU Mengyue, DI Rongrong, LIU Yu, LAI Yisheng. Design, synthesis and biological evaluation of five-membered heterocyclopyrimidines as MTH1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(4): 407-412. DOI: 10.11665/j.issn.1000-5048.20180404
    [3]ZHU Bao, JIN Shuanglong, GUO Yi, LI Yuezhen, ZHANG Yihua, LAI Yisheng. Design, synthesis and biological evaluation of pyridine-based IRAK4 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 670-674. DOI: 10.11665/j.issn.1000-5048.20170606
    [4]SUN Yinxing, WU Ying, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor memantine derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(5): 543-547. DOI: 10.11665/j.issn.1000-5048.20160506
    [5]MAO Zewei, WAN Chunping, ZHENG Xi, JIANG Yuan, RAO Gaoxiong. Synthesis and biological activities of novel hybrid compounds based on piperazines and acetophenones[J]. Journal of China Pharmaceutical University, 2014, 45(5): 517-521. DOI: 10.11665/j.issn.1000-5048.20140502
    [6]HE Liqin, WU Yaxian, FU Li, WANG Xiaoshan, ZHANG Yihua. Synthesis and biological evaluation of aminoalcohol gambogate as anti-tumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(5): 394-400. DOI: 10.11665/j.issn.1000-5048.20130503
    [7]WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403
    [8]WANG Xiaojian, FU Jihua, TANG Yiqun, YIN Dali, YOU Qidong. Synthesis,biological evaluation and molecule docking of novel desloratadine derivatives[J]. Journal of China Pharmaceutical University, 2013, 44(1): 39-43. DOI: 10.11665/j.issn.1000-5048.20130106
    [9]ZHU Xiong, HUANG Wen-long, GAO Cong, ZHU Yan, ZHANG Yin-guang, LING Yong. Synthesis and biological evaluation of novel difluorophenyl methanesulfinyl acetamide derivatives[J]. Journal of China Pharmaceutical University, 2012, 43(1): 16-20.
    [10]WANG Yu-bin, ZHANG Hui-bin, QIAN Hai, HUANG Wen-long. Synthesis and biological evaluation of 2-azetidinone derivatives as cholesterol absorption inhibitors[J]. Journal of China Pharmaceutical University, 2011, 42(3): 213-219.

Catalog

    Get Citation
    PDF
    XML
    Article views (903) PDF downloads (1517) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366147

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return